The roles of transporters in the human metabolic network
转运蛋白在人体代谢网络中的作用
基本信息
- 批准号:BB/P009042/2
- 负责人:
- 金额:$ 32.9万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2018
- 资助国家:英国
- 起止时间:2018 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
When you eat a foodstuff or a pill (i.e. a pharmaceutical drug) it is important that the relevant molecules go to the places where they will be of most benefit. How nutrients and drugs are absorbed and distributed (and eventually excreted) is thus a topic of high importance. When it goes wrong in the case of drugs they may not work properly or may even be toxic; this latter is known as an Adverse Drug Reaction, and they account for more than 5% of hospital admissions. Cells are bounded by cell membranes, whose job it is to stop them letting in any old rubbish. Instead, these membranes contain proteins called transporters that serve to ferry small molecules into and out of cells as part of the day-to-day reactions (metabolism) that keep us alive. Such transporters account for fully one third of the gene products involved in these biochemical networks. It turns out in general terms that, since all they recognise is a molecule, without knowing its 'purpose' (nutrient, drug, vitamin, etc), just these same transporters are involved in transporting nutrients, vitamins and pharmaceutical drugs into cells; the problem is that we do not tend to know which transporters transport which substances, and this correlation-based assessment is what we wish to find out here.To do this we shall study how transporter levels and the extent of small molecule uptake vary together between different cells and tissues; given enough of these paired measurements we can work out which changes in which transporters best account for the changes in small molecule uptake, including molecules not used in the learning phase, and can then test directly that they do indeed transport the molecules we claim. Because the transporter levels naturally vary between tissues they must naturally be controlled, and several substances (such as vitamin D) are known to affect these levels dramatically. This means that we can expect to be able to modulate the expression of transporters and different tissues by adding a second molecule (a so-called 'binary weapon'), and thereby 'force' particular substances to go only to those tissues. We shall test this by adding a library of small artificial (man-made) molecules (so-called 'fragments') and seeing which of them can do this (at least to some degree). Computer methods help us to find larger and more potent molecules that possess these same fragment signatures and that would therefore be predicted to have the desired targeting effects. Importantly, we shall curate all of the data in a web-accessible database.
当你吃食物或药丸(即药物)时,重要的是相关分子去到它们最受益的地方。因此,营养素和药物如何被吸收和分布(并最终排泄)是一个非常重要的话题。当药物出现问题时,它们可能无法正常工作,甚至可能有毒;后者被称为药物不良反应,占住院人数的5%以上。细胞由细胞膜包围,细胞膜的作用是阻止任何旧垃圾进入细胞。相反,这些细胞膜包含称为转运蛋白的蛋白质,作为维持我们生命的日常反应(代谢)的一部分,这些蛋白质可以将小分子运送到细胞内外。这些转运蛋白占这些生化网络中所涉及的基因产物的整整三分之一。一般来说,由于它们所识别的只是一个分子,而不知道它的“目的”,(营养素、药物、维生素等),正是这些相同的转运蛋白参与将营养素、维生素和药物转运到细胞中;问题是我们并不知道哪些转运体转运哪些物质,而这种基于相关性的评估正是我们希望在这里找到的。为此,我们将研究转运蛋白水平和小分子摄取的程度如何在不同细胞和组织之间共同变化;如果有足够的成对测量,我们就可以找出哪些转运蛋白的变化最能解释小分子摄取的变化,包括学习阶段不使用的分子,然后可以直接测试它们确实转运了我们所声称的分子。由于转运蛋白水平在组织之间自然变化,因此它们必须自然地受到控制,并且已知几种物质(如维生素D)会显着影响这些水平。这意味着我们可以通过添加第二种分子(所谓的“二元武器”)来调节转运蛋白和不同组织的表达,从而“迫使”特定物质只进入这些组织。我们将通过添加一个小的人工(人造)分子(所谓的“片段”)库来测试这一点,看看它们中的哪一个可以做到这一点(至少在某种程度上)。计算机方法帮助我们找到更大、更有效的分子,这些分子具有相同的片段特征,因此可以预测具有所需的靶向效果。重要的是,我们将在一个可通过网络访问的数据库中收集所有数据。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Transporter-Mediated Cellular Uptake and Efflux of Pharmaceutical Drugs and Biotechnology Products: How and Why Phospholipid Bilayer Transport Is Negligible in Real Biomembranes.
- DOI:10.3390/molecules26185629
- 发表时间:2021-09-16
- 期刊:
- 影响因子:0
- 作者:Kell DB
- 通讯作者:Kell DB
The biology of ergothioneine, an antioxidant nutraceutical.
- DOI:10.1017/s0954422419000301
- 发表时间:2020-12
- 期刊:
- 影响因子:5.7
- 作者:Borodina I;Kenny LC;McCarthy CM;Paramasivan K;Pretorius E;Roberts TJ;van der Hoek SA;Kell DB
- 通讯作者:Kell DB
Energetic evolution of cellular Transportomes.
- DOI:10.1186/s12864-018-4816-5
- 发表时间:2018-05-30
- 期刊:
- 影响因子:4.4
- 作者:Darbani B;Kell DB;Borodina I
- 通讯作者:Borodina I
Involvement of multiple influx and efflux transporters in the accumulation of cationic fluorescent dyes by Escherichia coli
- DOI:10.1186/s12866-019-1561-0
- 发表时间:2019-08-22
- 期刊:
- 影响因子:4.2
- 作者:Jindal, Srijan;Yang, Lei;Kell, Douglas B.
- 通讯作者:Kell, Douglas B.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Douglas Kell其他文献
Douglas Kell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Douglas Kell', 18)}}的其他基金
MUSERGEN: MultiUSER equipment for GENe identification in biosciences and biotechnology
MUSERGEN:用于生物科学和生物技术中基因识别的多用户设备
- 批准号:
BB/T017481/1 - 财政年份:2020
- 资助金额:
$ 32.9万 - 项目类别:
Research Grant
Untargeted metabolomics of serum samples during COVID-19 disease progression
COVID-19 疾病进展期间血清样本的非靶向代谢组学
- 批准号:
BB/V003976/1 - 财政年份:2020
- 资助金额:
$ 32.9万 - 项目类别:
Research Grant
MUSERMET: MultiUSER equipment for small molecule identification in untargeted METabolomics
MUSERMET:用于非靶向代谢组学中小分子鉴定的 MultiUSER 设备
- 批准号:
BB/S019030/1 - 财政年份:2019
- 资助金额:
$ 32.9万 - 项目类别:
Research Grant
Synthetic biology of transporters and other enzymes in yeast
酵母中转运蛋白和其他酶的合成生物学
- 批准号:
BB/N021037/2 - 财政年份:2019
- 资助金额:
$ 32.9万 - 项目类别:
Research Grant
GeneORator: a novel and high-throughput method for the synthetic biology-based improvement of any enzyme
GeneORator:一种新颖的高通量方法,用于基于合成生物学的任何酶的改进
- 批准号:
BB/S004955/1 - 财政年份:2019
- 资助金额:
$ 32.9万 - 项目类别:
Research Grant
Improving the penicillin fermentation by modelling and optimising its metabolic network and transporterome
通过建模和优化青霉素的代谢网络和转运体来改善青霉素发酵
- 批准号:
BB/R014744/1 - 财政年份:2018
- 资助金额:
$ 32.9万 - 项目类别:
Research Grant
MultiUSer equipment for high-throughput, high-content analysis in Industrial and Cellular biotechnology (MUSIC)
用于工业和细胞生物技术 (MUSIC) 中高通量、高内涵分析的多用户设备
- 批准号:
BB/R000093/1 - 财政年份:2017
- 资助金额:
$ 32.9万 - 项目类别:
Research Grant
The roles of transporters in the human metabolic network
转运蛋白在人体代谢网络中的作用
- 批准号:
BB/P009042/1 - 财政年份:2017
- 资助金额:
$ 32.9万 - 项目类别:
Research Grant
Synthetic biology of transporters and other enzymes in yeast
酵母中转运蛋白和其他酶的合成生物学
- 批准号:
BB/N021037/1 - 财政年份:2016
- 资助金额:
$ 32.9万 - 项目类别:
Research Grant
Continued development of ChEBI towards better usability for the systems biology and metabolic modelling community
持续开发 ChEBI,以提高系统生物学和代谢建模社区的可用性
- 批准号:
BB/K019783/1 - 财政年份:2013
- 资助金额:
$ 32.9万 - 项目类别:
Research Grant
相似国自然基金
棉铃虫葡萄糖转运蛋白(Glucose transporters)的分子鉴定
- 批准号:31601644
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
囊泡谷氨酸转运体作为老年痴呆症药物新靶标的研究
- 批准号:30973541
- 批准年份:2009
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
Targeting neuronal transport to ameliorate vincristine neurotoxicity
靶向神经元运输以改善长春新碱神经毒性
- 批准号:
10736789 - 财政年份:2023
- 资助金额:
$ 32.9万 - 项目类别:
Liver Targeting Dihydroquinolizinone (DHQ) Molecules as Hepatitis B Virus Antivirals with Reduced Toxicity
肝脏靶向二氢喹嗪酮 (DHQ) 分子作为乙型肝炎病毒抗病毒药物,毒性降低
- 批准号:
10593566 - 财政年份:2023
- 资助金额:
$ 32.9万 - 项目类别:
Neuronal ABCA7 loss of function and Alzheimer’s disease
神经元 ABCA7 功能丧失与阿尔茨海默病
- 批准号:
10629715 - 财政年份:2023
- 资助金额:
$ 32.9万 - 项目类别:
Structural and functional studies of YbtPQ for fighting bacterial infections
YbtPQ 对抗细菌感染的结构和功能研究
- 批准号:
10644889 - 财政年份:2023
- 资助金额:
$ 32.9万 - 项目类别:
Juvenile hormone transporters in disease vector physiology
疾病媒介生理学中的保幼激素转运蛋白
- 批准号:
10658269 - 财政年份:2023
- 资助金额:
$ 32.9万 - 项目类别:
Inhibition or evasion of P-glycoprotein-mediated drug transport
抑制或逃避 P-糖蛋白介导的药物转运
- 批准号:
10568723 - 财政年份:2023
- 资助金额:
$ 32.9万 - 项目类别:
A liver-on-chip platform to evaluate panels of clinically relevant gene variants for screening of xenobiotic compounds
用于评估临床相关基因变异组以筛选异生化合物的肝脏芯片平台
- 批准号:
10738215 - 财政年份:2023
- 资助金额:
$ 32.9万 - 项目类别:
Hsp40 and Hsp70 in Membrane Protein Triage
膜蛋白分类中的 Hsp40 和 Hsp70
- 批准号:
10718226 - 财政年份:2023
- 资助金额:
$ 32.9万 - 项目类别:
Dynamics and mechanism of sodium-dependent carboxylate transporters
钠依赖性羧酸转运蛋白的动力学和机制
- 批准号:
10577283 - 财政年份:2023
- 资助金额:
$ 32.9万 - 项目类别: